| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.STR.0000236053.37695.15 |
| P698 | PubMed publication ID | 16857945 |
| P50 | author | L Kristin Newby | Q77796327 |
| Carol A. Colton | Q87122812 | ||
| Cheryl D Bushnell | Q89728329 | ||
| Mitchell S V Elkind | Q90764032 | ||
| P2093 | author name string | Larry B Goldstein | |
| Virginia M Miller | |||
| Candice M Brown | |||
| David Herrington | |||
| Patricia Hurn | |||
| Paul Bray | |||
| Philip Gorelick | |||
| Gregory del Zoppo | |||
| Andra James | |||
| Barney Stern | |||
| Emily Choi | |||
| Gwendolyn Ford-Lynch | |||
| James Simpkins | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2387-2399 | |
| P577 | publication date | 2006-07-20 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group | |
| P478 | volume | 37 |
| Q34788471 | 17β-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus |
| Q37214486 | Accelerating action towards universal health coverage by applying a gender lens |
| Q57029579 | Alkaline phosphatase: a potential biomarker for stroke and implications for treatment |
| Q33714865 | Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke |
| Q38936426 | Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes |
| Q36634259 | Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke |
| Q33756940 | Estradiol is a potent protective, restorative, and trophic factor after brain injury. |
| Q35237116 | Estradiol: a hormone with diverse and contradictory neuroprotective actions |
| Q33699129 | Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro |
| Q38739583 | Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury |
| Q39094428 | Gender differences in neurologic emergencies part I: a consensus summary and research agenda on cerebrovascular disease |
| Q34354508 | Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion |
| Q37365916 | Gender differences in presenting and prodromal stroke symptoms |
| Q35883814 | Gender differences in presenting signs and symptoms of acute ischemic stroke: a population-based study |
| Q39945146 | Gender-specific differences in stroke knowledge, stroke risk perception and the effects of an educational multimedia campaign |
| Q99711219 | HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia |
| Q51769814 | Heritability of ischaemic stroke in women compared with men: a genetic epidemiological study. |
| Q34626471 | IMS updated recommendations on postmenopausal hormone therapy |
| Q36835343 | Inducible nitric oxide synthase and estradiol exhibit complementary neuroprotective roles after ischemic brain injury |
| Q85178768 | Is midlife spread causing a midlife stroke crisis for women in the USA? |
| Q33692623 | Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice |
| Q28221875 | Menopause and stroke and the effects of hormonal therapy |
| Q36901553 | Neuroprotective effects of estrogens following ischemic stroke. |
| Q46056858 | Persistent sex disparity in midlife stroke prevalence in the United States |
| Q35673223 | Premature menopause or early menopause and risk of ischemic stroke |
| Q37509299 | Review of the SPARCL trial and its subanalyses |
| Q37977532 | Risks and benefits of thrombolysis in the elderly |
| Q36246284 | Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013 |
| Q41657752 | Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities) |
| Q37248467 | Sex differences in stroke: a socioeconomic perspective |
| Q37149840 | Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes |
| Q34733347 | Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke |
| Q90554320 | Sex-Specific Physiology and Cardiovascular Disease |
| Q37058753 | Stroke and the female brain |
| Q51564494 | Stroke in Women: What is Different? |
| Q37080269 | Stroke in women: risk and prevention throughout the lifespan |
| Q28677503 | Stroke: working toward a prioritized world agenda |
| Q28677657 | Stroke: working toward a prioritized world agenda |
| Q28742458 | Stroke: working toward a prioritized world agenda |
| Q52599324 | The Influence of Sex in Stroke Thrombolysis: A Systematic Review and Meta-Analysis. |
| Q53085093 | The gender gap in stroke: a meta-analysis. |
| Q37879682 | Thrombolysis treatment for acute stroke: issues of efficacy and utilization in women |
| Q37088243 | Vascular actions of estrogens: functional implications |
| Q40060854 | Women and stroke knowledge: influence of age, race, residence location, and marital status |
| Q34039526 | Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort |
Search more.